血液输注设备市场：依产品、应用、最终用户、组件、模式、通路和技术划分－2025年至2032年全球预测

预计到 2032 年，输血设备市场规模将达到 78.3 亿美元，复合年增长率为 7.46%。

关键市场统计数据
基准年 2024	44亿美元
预计年份：2025年	47.3亿美元
预测年份 2032	78.3亿美元
复合年增长率 (%)	7.46%

输血设备领域正处于临床需求、技术创新和监管严格性三者交会的十字路口。设备自动化、数位化监测和材料科学的进步正在改变血液的采集、处理、储存和输送方式，促使临床医生和管理人员寻求更安全、更有效率的工作流程。本报告综合分析了这些技术和营运趋势，旨在为读者清晰展现未来一段时间内将影响输血设备应用和投资走向的动态和格局。

本分析并非仅关注产品目录，而是着重于临床效用、与诊疗路径的整合以及对血液安全和供应链韧性的影响。因此，从製造商到医院采购团队的相关人员都能切实了解设备功能如何与临床工作流程和监管要求相符。本引言为后续章节奠定了框架，重点阐述了决策者在评估产品系列、伙伴关係和实施策略时应考虑的关键转折点和实际问题。

自动化、数位整合、病患安全优先以及采购经济性正在同时重塑输血设备生态系统。

四大趋势正引领输血医疗设备领域发生变革：自动化和精密工程、对病人安全和病原体减少的日益重视、设备数据与临床资讯系统的数位整合，以及采购重点的转变（强调总体拥有成本和生命週期管理）。自动化技术已从基础机械化发展到基于复杂卡盒和盒式装置的半自动化系统以及全机器人平台，从而实现了更一致的处理流程并减少了人为错误。同时，新型流量控制技术和感测器驱动的电子监测器正在提高剂量精度，最大限度地减少溶血，并实现即时干预。

此外，人们对输血相关感染疾病的日益关注以及对成分特异性疗法的需求，使得白血球去除、成分分离和病原体减少策略成为优先事项。这些临床需求正促使製造商在过滤和离心系统方面进行创新，并开发能够无缝整合到医院工作流程中的床边设备。同时，采购决策正转向那些能够提供互通性、远距离诊断和可预测维护路径的解决方案。这些变化正在推动产品改进和商业模式的革新，从而更好地满足临床和营运需求，并重新定义产业内的竞争优势。

美国关税变化促使输血设备相关人员转变筹资策略、转向近岸外包并增强供应链韧性

美国近期关税调整为依赖全球供应链获取输血设备和组件的製造商、经销商和临床终端用户带来了新的挑战。关税变化影响了进口耗材和设备的到岸成本，尤其是血袋、采血套装以及用于血液分离和成分分离的一次性产品等大宗商品，并正在改变筹资策略。因此，各机构正在重新评估供应商多元化和国内生产的可行性，以降低关税波动和运输中断带来的风险。

为此，许多公司正在评估近岸外包和区域製造伙伴关係关係，以维持利润率并确保及时供货。同时，其他公司正在调整定价和合约条款，以应对关税可能带来的成本转嫁。此外，血库和医院的采购部门也日益呼吁提高成本透明度，签订长期供应协议，并紧急时应对计画，以应对关税带来的复杂性和合规性问题。总而言之，这些趋势正在推动投资转向增强供应链韧性，例如建立本地库存缓衝、采用多源策略以及与物流合作伙伴更紧密地合作，以应对关税造成的成本波动和营运风险。

全面的細項分析揭示了产品类型、临床应用、最终用户、组件、供应模式、分销管道和技术如何相互作用，从而影响医疗设备的选择。

细分市场分析揭示了临床需求、营运限制和采购政策对输血设备领域产品开发和商业化策略的微妙影响。就产品特性而言，产品范围涵盖了从复杂的血浆分离系统（单针和双针配置）到单袋或多袋血袋。血液采集装置设计为封闭式系统以降低污染风险，或开放式系统以适应低成本采血场景。血浆分离装置根据通量需求提供自动和手动配置。白血球去除过滤器依临床时间和物流需求，分为床边型和预存型。输液帮浦分为用于精确小剂量输注的注射器型和用于持续输注的容量型。这些产品层面的选择直接影响采购规范和临床工作流程。

基于应用领域的分类进一步明确了使用模式，涵盖了以采集为中心的血液成分分离术（区分采集型血液成分分离术和治疗型血液成分分离术）以及包括专用血液成分分离术和全血采集方法在内的血液采集工作流程。血液成分分离采用离心或过滤方法，而白血球去除可根据处理量和临床目标采用离心或过滤机制。输血程序本身的特征是持续输血与间歇性输血，影响输血设备的选择和监测通讯协定。

不同的终端使用者也影响产品定位和服务模式。政府和私部门的血库和捐血中心需要高通量、耐用且耗材供应稳定的系统，而公立和私立医院则需要能够融入患者照护流程并满足不同技能等级医护人员需求的设备。组件细分体现了血浆、血小板、红血球和白血球不同的处理和储存需求。血浆亚型包括冷沉淀和新鲜冷冻血浆，血小板来源包括血小板分离术和血小板池，白血球分为粒细胞浓缩液和淋巴细胞浓缩液，每种都有其独特的处理和品管要求。

部署模式和通路的细分也会影响产品的采用模式。自动化、手动和半自动化模式（自动化产品涵盖从全自动桌面设备到机器人系统，而半自动化设备则采用基于墨盒或盒式设计）决定了资本投入和培训需求，而分销渠道，例如直销、医院药房（集中式或院内）、透过B2B平台或製造商网站进行的在线销售以及零售药房，则影响着产品的可及性、摩擦和预期服务。最后，传统流量控制方法（例如重力或压力注射）与基于微处理器或感测器驱动的电子流量控制解决方案之间的技术选择，在安全性、可追溯性和与临床资讯系统的整合方面，会产生不同的价值提案。了解这些相互关联的细分维度，有助于相关人员优化产品蓝图，锁定合适的最终用户，并设计符合临床和营运实际情况的服务模式。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和差异化采用模式正在影响产品策略和监管方式。

区域趋势对输血器材领域的临床实践、采购行为、监管预期以及创新扩散有显着影响。在美洲，先进的临床基础设施和集中的研究生态系统正在加速自动化和电子流量控制技术的应用，而集中化的报销机制和大型医院系统则催生了对扩充性解决方案和完善的售后支援的需求。在欧洲、中东和非洲地区，不同司法管辖区的监管一致性、医院资金筹措机制的多样性以及不同的捐血系统共同造就了一个异质性市场，其中既有先进器械，也有适应当地资源的器械。

在亚太地区，医疗基础设施的快速扩张、血液服务现代化进程的推进以及强大的製造业基础，共同推动了国内创新和出口导向生产。该地区的转型经济体正投资于可分阶段整合的半自动化和模组化系统，而高所得市场则优先考虑完全自动化和无缝的数位化互通性。在所有地区，当地的监管差异、劳动力能力和供应链物流都会影响设备规格製定和临床应用的速度。因此，製造商和经销商必须采取针对特定地区的策略，以应对资金筹措模式、监管时间表、培训要求和备件物流等问题，从而确保设备的持续应用和营运成功。

深入了解输血设备市场竞争格局以及创新、伙伴关係和服务品质的策略定位，这些因素共同决定了市场领导地位。

输血设备领域的竞争格局由产品创新、服务模式、监管专业知识和伙伴关係关係生态系统决定。主要企业透过投资自动化、基于感测器的监测和耗材设计来实现差异化，从而减少操作人员的差异并提高病患安全。同时，新兴医疗技术公司和专业契约製造製造商正在推出针对价格和易用性缺口的创新产品，涵盖从符合人体工学的血液分离模组到低成本过滤耗材等各个方面。

医疗设备製造商与临床网路之间的策略联盟日益普遍，从而能够实现产品迭代检验、真实世界效能回馈和快速引进週期。建立完善的上市后监测、远距离诊断和培训专案的公司能够加强客户关係并降低终端用户生命週期成本。此外，投资于可扩展的製造地和多元化分销管道的公司能够更好地应对力关税波动和供应链中断。最终，能够将监管能力与模组化产品架构以及针对资源丰富和资源受限环境量身定制的服务相结合的企业将获得竞争优势。

针对领导者的具体建议，重点在于互通性、供应链韧性、提升服务品质以及围绕临床医生需求设计产品。

产业领导者可以透过以下方式将洞察转化为优势：使产品蓝图与临床工作流程保持一致，优先考虑互通性，并投资于供应链韧性。首先，医疗设备开发商应整合感测器和微处理器控制，以实现增强的安全功能和数据驱动的维护，同时确保与电子健康记录 (EHR) 和输血管理系统的互通性，从而简化临床医生的工作流程。其次，製造商应寻求灵活的生产结构和区域伙伴关係，以降低关税风险并缩短前置作业时间，从而实现具有竞争力的价格和可靠的服务交付。

此外，各机构应透过拓展服务提案，降低采购方的整体拥有成本，服务内容不仅限于保固和维修，还包括培训课程、远距离诊断和耗材管理项目。与临床中心合作产生真实世界数据 (RWE) 有助于提高可靠性并促进报销谈判。最后，医院和血站的采购和临床负责人应采用多供应商合作策略和标准化规范，强调相容性、培训支援和可预测的供应。这些措施可降低营运风险并提升长期价值实现。

一种稳健的混合调查方法，整合了监管审查、技术检验和临床医生见解，以确保设备智慧的可靠性。

调查方法结合了已发布的监管文件、技术标准和同行评审临床文献的系统性回顾，以及对临床医生、采购负责人和设备技术人员的初步定性访谈。透过对供应商文件、技术白皮书和观察到的临床通讯协定检验资料三角验证，以确认功能声明并识别新兴的使用模式。透过对设备功能、培训要求和上市后支援模式的交叉检验，应用了严谨的分析方法，并在评估推广应用的驱动因素和障碍时考虑了区域监管路径。

在条件允许的情况下，我们透过多个独立资讯来源和临床终端使用者的观点来验证研究结果，以确保关于设备效用和操作适用性的论点能够​​反映真实的临床工作流程。调查方法的局限性包括已发表的性能数据存在差异以及部分上市后结果的保密性，但这些局限性已通过有针对性的专家咨询得到缓解。这种混合方法提供了可操作的见解，能够为战略决策提供信息，而无需依赖保密的市场规模估算或预测。

总之，我们的研究强调需要製定整合策略，将创新、临床诚信和供应链远见结合起来，以优化输血实践。

总之，输血器材产业正日益成熟，形成一个更复杂的生态系统，器械自动化、数位化控制和供应链策略决定着临床和商业性的成功。诸如白血球去除、精准的血液成分分离和安全输血等临床需求，正在推动产品需求和服务期望的差异化。同时，关税波动和区域监管差异等外部压力，迫使製造商和医疗系统在采购、本地化和全生命週期支援方面更加谨慎。

展望未来，那些将产品开发与临床工作流程相结合、投资于互通性和感测器驱动技术、并采取稳健的生产和分销策略的机构，将更有利于实现患者安全目标和医疗机构的采购优先事项。这一结论凸显了整合技术创新、营运前瞻性和强有力的临床合作的策略的重要性——这对于充分发挥现代输血设备技术的潜力至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 采用病原体减少技术提高输血过程中的血液安全性
• 整合智慧感测器和物联网技术，实现血液製品在储存和运输过程中品质的即时监测
• 提高自动化血型鑑定和抗体筛检的应用率，以减少输血错误
• 开发携带式血液加温/冷却系统，用于紧急医疗护理中的快速输血支援。
• 床边照护现场血液分析仪的普及，使得在床边进行即时相容性检测成为可能。
• 利用人工智慧演算法预测患者输血需求并优化库存管理
• 为最大限度降低输血器具的污染风险，对一次性无菌输液管和接头的需求日益增长。
• 穿戴式连续血红素监测设备可实现非侵入性输血后评估。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 输血设备市场：依产品分类

• 血液分离系统
  • 双针
  • 单针
• 输血袋
  • 多口袋
  • 单口袋
• 采血套装
  • 闭型
  • 开放型
• 组件分离装置
  • 自动分离装置
  • 手动分离器
• 白血球去除过滤器
  • 床头
  • 预储存
• 点滴帮浦
  • 注射器
  • 体积测量

第九章 输血设备市场：依应用领域划分

• 血液分离术
  • 血液采集分离术
  • 治疗性血液分离术
• 血液收集
  • 血球分离术采集
  • 全血采集
• 组分分离
  • 离心分离法
  • 过滤法
• 白血球去除
  • 离心分离法
  • 过滤法
• 输血
  • 持续输血
  • 间歇性输血

第十章 以最终用户分類的输血设备市场

• 血库和捐血中心
  • 政府机构
  • 私人中心
• 医院
  • 私立医院
  • 公立医院

第十一章 按组件分類的输血设备市场

• 电浆
  • 冷沉淀物
  • 新鲜冷冻血浆
• 血小板
  • 血小板分离术
  • 混合血小板
• 红血球
• 白血球
  • 粒细胞浓缩液
  • 淋巴球浓缩物

第十二章 血液输注设备市场（依类型划分）

• 自动化
  • 全自动桌面
  • 机器人系统
• 手动输入
• 半自动
  • 墨水匣类型
  • 盒式

第十三章 按通路分類的输血设备市场

• 直销
• 医院药房
  • 集中
  • 在医院里
• 线上销售
  • B2B平台
  • 製造商网站
• 零售药房

第十四章 输血设备市场：依技术划分

• 传统流量控制
  • 重力型
  • 压力注射法
• 电子流量控制
  • 基于微处理器的
  • 基于感测器的

第十五章 输血设备市场：依地区划分

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十六章 血液输注设备市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十七章 各国输血设备市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十八章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Haemonetics Corporation
  • Baxter International Inc.
  • Grifols, SA
  • Macopharma SA
  • Cerus Corporation
  • Immucor, Inc.

The Blood Transfusion Devices Market is projected to grow by USD 7.83 billion at a CAGR of 7.46% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 4.40 billion
Estimated Year [2025]	USD 4.73 billion
Forecast Year [2032]	USD 7.83 billion
CAGR (%)	7.46%

The evolving field of blood transfusion devices is at the intersection of clinical necessity, engineering innovation, and regulatory rigor. Advances in device automation, digital monitoring, and materials science are reshaping how blood is collected, processed, stored, and delivered, while clinicians and administrators seek safer, more efficient workflows. This report synthesizes these technological and operational trends to give readers a clear orientation of the landscape and the forces that will shape adoption and investment trajectories in the near term.

Rather than focusing solely on product catalogs, the analysis emphasizes clinical utility, integration into care pathways, and the implications for blood safety and supply chain resilience. Consequently, stakeholders from manufacturers to hospital procurement teams will gain a practical understanding of how device capabilities intersect with clinical workflows and regulatory expectations. This introduction frames the subsequent sections by highlighting pivotal transitions and the practical considerations that decision-makers should weigh when evaluating product portfolios, partnerships, and deployment strategies.

How automation, digital integration, patient safety priorities, and procurement economics are simultaneously reshaping the blood transfusion device ecosystem

The blood transfusion device landscape is experiencing transformative shifts driven by four converging trends: automation and precision engineering, intensified focus on patient safety and pathogen mitigation, digital integration of device data into clinical information systems, and evolving procurement priorities that emphasize total cost of ownership and lifecycle management. Automation has progressed from basic mechanization to sophisticated cartridge- and cassette-based semi-automated systems as well as fully robotic platforms, enabling more consistent processing and reduced human error. In parallel, emerging flow control technologies and sensor-driven electronic monitors are improving dose accuracy, minimizing hemolysis, and enabling real-time intervention.

Moreover, heightened awareness of transfusion-transmitted infections and the demand for component-specific therapies have prioritized leukocyte reduction, component separation, and pathogen reduction strategies. These clinical drivers have prompted manufacturers to innovate filtration and centrifugal systems as well as bedside devices that integrate seamlessly with hospital workflows. At the same time, procurement decision-making is shifting toward solutions that offer interoperability, remote diagnostics, and predictable maintenance pathways. Taken together, these shifts are catalyzing product refinements and commercial models that better address clinical and operational imperatives, thereby redefining competitive differentiation within the sector.

Tariff changes in the United States prompting strategic shifts in sourcing, nearshoring, and supply chain resilience for blood transfusion device stakeholders

Recent tariff adjustments in the United States have introduced new complexities for manufacturers, distributors, and clinical end users that rely on global supply chains for blood transfusion devices and components. Tariff changes influence sourcing strategies by altering landed costs for imported consumables and equipment, particularly for high-volume items such as blood bags, collection sets, and disposables used in apheresis and component separation. As a result, organizations are reassessing supplier diversification and onshore manufacturing viability to mitigate exposure to tariff volatility and shipping disruptions.

In response, many firms are evaluating nearshoring and regional manufacturing partnerships to preserve margin and maintain timely supply, while others are adjusting pricing and contract terms to account for the potential pass-through of duties. Simultaneously, procurement teams within blood banks and hospitals are increasingly demanding clearer cost transparency, longer-term supply agreements, and contingency plans that address customs complexity and compliance. These reactions collectively shift investment toward supply chain resilience measures, including local inventory buffers, multi-sourcing strategies, and closer collaboration with logistics partners to manage tariff-induced cost variability and operational risk.

Comprehensive segmentation clarity revealing how product types, clinical applications, end users, components, modes, distribution channels, and technologies intersect to drive device selection

Segmentation reveals the nuanced ways clinical requirements, operational constraints, and procurement preferences shape product development and commercialization tactics within the blood transfusion device arena. When product distinctions are considered, offerings range from complex apheresis systems-available in single needle and double needle configurations-to blood bags that come as single pocket or multi pocket formats; blood collection sets are engineered as closed systems to minimize contamination risk or open systems for lower-cost collection scenarios; component separators appear as automated and manual units to serve different throughput needs; leukocyte reduction filters are positioned for bedside application or pre-storage processing to match clinical timing and logistics; and transfusion pumps are split between syringe-based devices for small-volume precision and volumetric pumps for continuous infusion demands. These product-level choices directly affect procurement specifications and clinical workflows.

Application-based segmentation further clarifies usage patterns, extending from collection-focused apheresis-distinguished between collection apheresis procedures and therapeutic apheresis interventions-to blood collection workflows that include dedicated apheresis collection and whole blood collection approaches. Component separation is executed through centrifugation-based or filtration-based methods, and leukocyte reduction can employ either centrifugation or filtration mechanisms depending on throughput and clinical objectives. Transfusion procedures themselves are characterized by continuous transfusion modalities versus intermittent transfusion episodes, impacting device selection and monitoring protocols.

End user distinctions also guide product positioning and service models, with blood banks and donation centers-operating in government-run or private configurations-demanding high-throughput, durable systems and predictable consumable supply, while hospitals, whether private or public, require devices that integrate into patient care pathways and accommodate varied staffing competencies. Component-wise segmentation recognizes the different handling and storage needs for plasma, platelets, red blood cells, and white blood cells; plasma subtypes include cryoprecipitate and fresh frozen plasma, platelets are sourced as apheresis platelets or pooled platelets, and white blood cells are categorized into granulocyte concentrates and lymphocyte concentrates, each presenting specific processing and quality control requirements.

Mode and distribution channel segmentation further influence adoption patterns; automated, manual, and semi-automated modes-where automated offerings range from fully automated desktop units to robotic systems and semi-automated devices use cartridge- or cassette-based designs-determine capital intensity and training needs, while distribution channels such as direct sales, hospital pharmacies (centralized or in-house), online sales through B2B platforms or manufacturer websites, and retail pharmacies shape accessibility, procurement friction, and service expectations. Finally, technology choices between conventional flow control methods, including gravity-fed and pressure infusion approaches, and electronic flow control solutions that are microprocessor-based or sensor-driven create distinct value propositions related to safety, traceability, and integration with clinical information systems. Understanding these interconnected segmentation axes enables stakeholders to refine product roadmaps, target the right end users, and design service models that align with clinical and operational realities.

Regional dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping product strategies and regulatory approaches

Regional dynamics exert substantial influence on clinical practice, procurement behavior, regulatory expectations, and innovation diffusion across the blood transfusion device sector. In the Americas, advanced clinical infrastructures and concentrated research ecosystems accelerate adoption of automated and electronic flow control technologies, while concentrated reimbursement frameworks and large hospital systems create demand for scalable solutions and robust post-market support. Conversely, the Europe, Middle East & Africa region presents a heterogeneous landscape in which regulatory alignment across jurisdictions, variable hospital funding mechanisms, and differing blood donation systems lead to a mix of advanced and resource-adapted device deployments.

In Asia-Pacific, rapid healthcare infrastructure expansion, growing blood service modernization efforts, and a strong manufacturing base combine to drive both domestic innovation and export-oriented production. Transitional economies within the region are investing in semi-automated and modular systems that can be integrated incrementally, whereas high-income markets prioritize full automation and seamless digital interoperability. Across all regions, local regulatory nuances, workforce capabilities, and supply chain logistics influence device specification decisions and the pace of clinical acceptance. Consequently, manufacturers and distributors must adopt regionally tailored strategies that address funding models, regulatory timelines, training requirements, and spare parts logistics to ensure sustained adoption and operational success.

Competitive realities and strategic positioning insights that reveal how innovation, partnerships, and service excellence determine leadership in transfusion device markets

Competitive dynamics in the blood transfusion device landscape are defined by product innovation, service models, regulatory expertise, and partnership ecosystems. Leading companies tend to differentiate through investments in automation, sensor-enabled monitoring, and consumable design that reduce operator variability and improve patient safety. At the same time, emerging medtech entrants and specialized contract manufacturers are introducing niche innovations, from ergonomic apheresis modules to low-cost filtration consumables, that target gaps in affordability and usability.

Strategic partnerships between device manufacturers and clinical networks are increasingly common, enabling iterative product validation, real-world performance feedback, and faster adoption cycles. Companies that establish robust post-market surveillance, remote diagnostics, and training programs strengthen customer relationships and reduce lifecycle costs for end users. Furthermore, firms that invest in scalable manufacturing footprints and diversified distribution channels are better positioned to respond to tariff fluctuations and supply chain shocks. Ultimately, competitive advantage accrues to organizations that couple regulatory competence with modular product architectures and service offerings tailored to both high-resource and resource-constrained environments.

Actionable recommendations for leaders focusing on interoperability, supply chain resilience, service excellence, and clinician-aligned product design

Industry leaders can take concrete actions to convert insight into advantage by aligning product roadmaps with clinical workflows, prioritizing interoperability, and investing in supply chain resilience. First, device developers should embed sensors and microprocessor controls to enhance safety features and enable data-driven maintenance, while ensuring interoperability with electronic health records and transfusion management systems to streamline clinician workflows. Secondly, manufacturers should pursue flexible manufacturing and regional partnerships to reduce tariff exposure and shorten lead times, enabling competitive pricing and reliable service delivery.

Additionally, organizations should expand their service propositions beyond warranty and repair to include training curricula, remote diagnostics, and consumable management programs that lower total cost of ownership for buyers. Collaborations with clinical centers for real-world evidence generation will accelerate credibility and support reimbursement discussions. Finally, procurement and clinical leaders within hospitals and blood centers should adopt multi-vendor engagement strategies and standardized specifications that emphasize compatibility, training support, and predictable supply arrangements; these measures will mitigate operational risk and improve long-term value realization.

Robust mixed-methods research approach integrating regulatory review, technical validation, and clinician insights to ensure credible device intelligence

The research methodology combined a systematic review of publicly available regulatory documents, technical standards, and peer-reviewed clinical literature with primary qualitative interviews of clinicians, procurement professionals, and device engineers. Data was triangulated using supplier documentation, technical white papers, and observed clinical protocols to validate feature claims and identify emergent usage patterns. Analytical rigor was applied through cross-validation of device functionality, training requirements, and post-market support models, while attention to regional regulatory pathways informed assessments of adoption enablers and barriers.

Where possible, insights were corroborated through multiple independent sources and clinical end-user perspectives to ensure that assertions about device utility and operational fit reflect real-world workflows. Limitations of the methodology include variability in publicly disclosed performance data and the proprietary nature of some post-market outcomes, which were mitigated through targeted expert consultations. This mixed-methods approach yields actionable intelligence designed to inform strategic decisions without relying on proprietary market sizing or forecasting estimates.

Concluding synthesis emphasizing the necessity of integrated strategies that combine innovation, clinical alignment, and supply chain foresight to optimize transfusion practices

In conclusion, the blood transfusion device sector is maturing into a more sophisticated ecosystem where device automation, digital control, and supply chain strategy determine clinical and commercial success. Clinical imperatives such as leukocyte reduction, precise component separation, and safe transfusion delivery are driving differentiated product requirements and service expectations. Meanwhile, external pressures including tariff variability and regional regulatory diversity compel manufacturers and health systems to be more deliberate about sourcing, localization, and lifecycle support.

Moving forward, organizations that align product development with clinical workflows, invest in interoperable and sensor-driven technologies, and adopt resilient manufacturing and distribution strategies will be better positioned to meet both patient safety objectives and institutional procurement priorities. This conclusion underscores the importance of integrated strategies that combine technical innovation, operational foresight, and strong clinical collaborations to realize the full potential of modern transfusion device technology.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Adoption of pathogen reduction technologies improving blood safety in transfusion procedures
• 5.2. Integration of smart sensors and IoT for real-time monitoring of blood unit quality during storage and transport
• 5.3. Rising implementation of automated blood typing and antibody screening to reduce transfusion errors
• 5.4. Development of portable blood warming and cooling systems for rapid transfusion support in emergency care
• 5.5. Expansion of point-of-care blood analysis devices enabling immediate bedside compatibility testing
• 5.6. Use of artificial intelligence algorithms to predict patient transfusion needs and optimize inventory management
• 5.7. Growing demand for single-use sterile tubing and connectors to minimize contamination risks in transfusion sets
• 5.8. Emergence of wearable continuous hemoglobin monitoring devices for non-invasive post-transfusion assessment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Transfusion Devices Market, by Product

• 8.1. Apheresis System
  • 8.1.1. Double Needle
  • 8.1.2. Single Needle
• 8.2. Blood Bag
  • 8.2.1. Multi Pocket
  • 8.2.2. Single Pocket
• 8.3. Blood Collection Set
  • 8.3.1. Closed System
  • 8.3.2. Open System
• 8.4. Component Separator
  • 8.4.1. Automated Separator
  • 8.4.2. Manual Separator
• 8.5. Leukocyte Reduction Filter
  • 8.5.1. Bedside
  • 8.5.2. Pre Storage
• 8.6. Transfusion Pump
  • 8.6.1. Syringe
  • 8.6.2. Volumetric

9. Blood Transfusion Devices Market, by Application

• 9.1. Apheresis
  • 9.1.1. Collection Apheresis
  • 9.1.2. Therapeutic Apheresis
• 9.2. Blood Collection
  • 9.2.1. Apheresis Collection
  • 9.2.2. Whole Blood Collection
• 9.3. Component Separation
  • 9.3.1. Centrifugation Based
  • 9.3.2. Filtration Based
• 9.4. Leukocyte Reduction
  • 9.4.1. Centrifugation Based
  • 9.4.2. Filtration Based
• 9.5. Transfusion
  • 9.5.1. Continuous Transfusion
  • 9.5.2. Intermittent Transfusion

10. Blood Transfusion Devices Market, by End User

• 10.1. Blood Banks & Donation Centers
  • 10.1.1. Government Centers
  • 10.1.2. Private Centers
• 10.2. Hospitals
  • 10.2.1. Private Hospitals
  • 10.2.2. Public Hospitals

11. Blood Transfusion Devices Market, by Component

• 11.1. Plasma
  • 11.1.1. Cryoprecipitate
  • 11.1.2. Fresh Frozen Plasma
• 11.2. Platelets
  • 11.2.1. Apheresis Platelets
  • 11.2.2. Pooled Platelets
• 11.3. Red Blood Cells
• 11.4. White Blood Cells
  • 11.4.1. Granulocyte Concentrates
  • 11.4.2. Lymphocyte Concentrates

12. Blood Transfusion Devices Market, by Mode

• 12.1. Automated
  • 12.1.1. Fully Automated Desktop
  • 12.1.2. Robotic Systems
• 12.2. Manual
• 12.3. Semi Automated
  • 12.3.1. Cartridge Based
  • 12.3.2. Cassette Based

13. Blood Transfusion Devices Market, by Distribution Channel

• 13.1. Direct Sales
• 13.2. Hospital Pharmacies
  • 13.2.1. Centralized
  • 13.2.2. In House
• 13.3. Online Sales
  • 13.3.1. B2B Platforms
  • 13.3.2. Manufacturer Websites
• 13.4. Retail Pharmacies

14. Blood Transfusion Devices Market, by Technology

• 14.1. Conventional Flow Control
  • 14.1.1. Gravity Fed
  • 14.1.2. Pressure Infusion
• 14.2. Electronic Flow Control
  • 14.2.1. Microprocessor Based
  • 14.2.2. Sensor Based

15. Blood Transfusion Devices Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Blood Transfusion Devices Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Blood Transfusion Devices Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. Competitive Landscape

• 18.1. Market Share Analysis, 2024
• 18.2. FPNV Positioning Matrix, 2024
• 18.3. Competitive Analysis
  • 18.3.1. Becton, Dickinson and Company
  • 18.3.2. Fresenius Kabi AG
  • 18.3.3. Terumo Corporation
  • 18.3.4. B. Braun Melsungen AG
  • 18.3.5. Haemonetics Corporation
  • 18.3.6. Baxter International Inc.
  • 18.3.7. Grifols, S.A.
  • 18.3.8. Macopharma SA
  • 18.3.9. Cerus Corporation
  • 18.3.10. Immucor, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AMERICAS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. NORTH AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. LATIN AMERICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. EUROPE BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. MIDDLE EAST BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. AFRICA BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. ASEAN BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. GCC BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. EUROPEAN UNION BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. BRICS BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. G7 BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. NATO BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 32. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 33. BLOOD TRANSFUSION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 34. BLOOD TRANSFUSION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. BLOOD TRANSFUSION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY DOUBLE NEEDLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE NEEDLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BAG, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MULTI POCKET, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SINGLE POCKET, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY REGION, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION SET, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATOR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY AUTOMATED SEPARATOR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY MANUAL SEPARATOR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BEDSIDE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRE STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION PUMP, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY VOLUMETRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COLLECTION APHERESIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY THERAPEUTIC APHERESIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY LEUKOCYTE REDUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CENTRIFUGATION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY REGION, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FILTRATION BASED, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CONTINUOUS TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY INTERMITTENT TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY BLOOD BANKS & DONATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY GOVERNMENT CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 249. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 250. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 255. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 256. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 257. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 260. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 261. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 262. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 263. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 264. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 265. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 266. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 267. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 268. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 269. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 270. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 271. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 272. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 273. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2018-2024 (USD MILLION)
• TABLE 274. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, 2025-2032 (USD MILLION)
• TABLE 275. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 276. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 277. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 278. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 279. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 280. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 281. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 282. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 283. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 284. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 285. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 286. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 287. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 288. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 289. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 290. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 291. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 292. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 293. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2018-2024 (USD MILLION)
• TABLE 294. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, 2025-2032 (USD MILLION)
• TABLE 295. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 296. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 297. GLOBAL BLOOD TRANSFUSION DEVICES MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2024